Search research articles
Contact Us
Filters
Showing results (41-50 of 46) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 46 results.
Critical Care Medicine
|
September 30, 2022
Impact of a Nurse-Driven Patient Empowerment Intervention on the Reduction in Patients' Anxiety and Depression During ICU Discharge: A Randomized Clinical Trial
Cecilia Cuzco, Pedro Castro, Raquel Marín Pérez, et al.
Brain, Behavior, and Immunity
|
May 4, 2025
Activation of central cannabinoid type 2 receptors, but not on peripheral immune cells, is required for endocannabinoid-mediated neuroprotection in Parkinson's disease
Leyre Ayerra, Miguel Angel Abellanas, Clara Vidaurre, et al.
Journal of Neuroinflammation
|
September 30, 2021
Potentiation of amyloid beta phagocytosis and amelioration of synaptic dysfunction upon FAAH deletion in a mouse model of Alzheimer's disease
Gonzalo Ruiz-Pérez, Samuel Ruiz de Martín Esteban, Sharai Marqués, et al.
Frontiers in Pharmacology
|
June 1, 2022
Cannabinoid CB<sub>2</sub> Receptors Modulate Microglia Function and Amyloid Dynamics in a Mouse Model of Alzheimer's Disease
Samuel Ruiz de Martín Esteban, Irene Benito-Cuesta, Itziar Terradillos, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 20, 2022
Insulin regulates neurovascular coupling through astrocytes
Ana M Fernandez, Laura Martinez-Rachadell, Marta Navarrete, et al.
Journal of the American Chemical Society
|
September 9, 2020
Development of High-Specificity Fluorescent Probes to Enable Cannabinoid Type 2 Receptor Studies in Living Cells
Roman C Sarott, Matthias V Westphal, Patrick Pfaff, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 46) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 46 results.
Critical Care Medicine
|
September 30, 2022
Impact of a Nurse-Driven Patient Empowerment Intervention on the Reduction in Patients' Anxiety and Depression During ICU Discharge: A Randomized Clinical Trial
Cecilia Cuzco, Pedro Castro, Raquel Marín Pérez, et al.
Brain, Behavior, and Immunity
|
May 4, 2025
Activation of central cannabinoid type 2 receptors, but not on peripheral immune cells, is required for endocannabinoid-mediated neuroprotection in Parkinson's disease
Leyre Ayerra, Miguel Angel Abellanas, Clara Vidaurre, et al.
Journal of Neuroinflammation
|
September 30, 2021
Potentiation of amyloid beta phagocytosis and amelioration of synaptic dysfunction upon FAAH deletion in a mouse model of Alzheimer's disease
Gonzalo Ruiz-Pérez, Samuel Ruiz de Martín Esteban, Sharai Marqués, et al.
Frontiers in Pharmacology
|
June 1, 2022
Cannabinoid CB<sub>2</sub> Receptors Modulate Microglia Function and Amyloid Dynamics in a Mouse Model of Alzheimer's Disease
Samuel Ruiz de Martín Esteban, Irene Benito-Cuesta, Itziar Terradillos, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 20, 2022
Insulin regulates neurovascular coupling through astrocytes
Ana M Fernandez, Laura Martinez-Rachadell, Marta Navarrete, et al.
Journal of the American Chemical Society
|
September 9, 2020
Development of High-Specificity Fluorescent Probes to Enable Cannabinoid Type 2 Receptor Studies in Living Cells
Roman C Sarott, Matthias V Westphal, Patrick Pfaff, et al.
Page
of 5